Sujith Samarasinghe

Great Ormond Street Hospital For Children
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.

EARLY RESPONSE AND GENETICS DEFINE RELAPSE RISK AFTER FRONTLINE BLINATUMOMAB IN CHILDHOOD B-ALL: A COHORT STUDY.

Journal: Blood advances

Published: May 07, 2026

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Reduced-intensity reinduction for children and young persons with relapsed acute lymphoblastic leukemia.

Journal: Leukemia

Published: October 06, 2025

Blinatumomab in Childhood B-Cell Acute Lymphoblastic Leukemia.

Blinatumomab in Childhood B-Cell Acute Lymphoblastic Leukemia.

Journal: The New England journal of medicine

Published: June 11, 2025

Late Onset Blinatumomab-Related Neurotoxicity in a Child With B-Cell Acute Lymphoblastic Leukemia.

Late Onset Blinatumomab-Related Neurotoxicity in a Child With B-Cell Acute Lymphoblastic Leukemia.

Journal: Pediatric blood & cancer

Published: June 03, 2025

High-Dose Methotrexate in Children and Young Adults With ALL and Lymphoblastic Lymphoma: Results of the Randomized Phase III Study UKALL 2011.

High-Dose Methotrexate in Children and Young Adults With ALL and Lymphoblastic Lymphoma: Results of the Randomized Phase III Study UKALL 2011.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 07, 2025

Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial.

Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial.

Journal: Blood advances

Published: December 11, 2024

Donor-type bone marrow aplasia following hematopoietic stem cell transplantation in a child with a novel SAMD9L variant.

Donor-type bone marrow aplasia following hematopoietic stem cell transplantation in a child with a novel SAMD9L variant.

Journal: Hematology (Amsterdam, Netherlands)

Published: April 10, 2024

Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.

Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.

Journal: Blood cancer journal

Published: December 01, 2023

Benefits for children with suspected cancer from routine whole-genome sequencing.

Benefits for children with suspected cancer from routine whole-genome sequencing.

Journal: Nature medicine

Published: November 20, 2023

Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL.

Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 15, 2023

Outcomes of hematopoietic stem cell transplantation in 813 pediatric patients with Fanconi anemia.

Outcomes of hematopoietic stem cell transplantation in 813 pediatric patients with Fanconi anemia.

Journal: Blood

Published: October 19, 2023

Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALL.

Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALL.

Journal: Blood advances

Published: July 19, 2023

Showing 1-12 of 70

Last Updated: 09/26/2026